Purchases and Sales Made in Q1 2025 in Olema Pharmaceuticals, Inc. (OLMA)
This table provides information about the institutional ownership of Olema Pharmaceuticals, Inc. (OLMA) during Q1 2025. The information is specifically focused on institutions that hold shares of Olema Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 14, 2025
Q1 2025
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-92.7K- 58.93% |
$349K - $592K
|
64.6K
$295K
|
|
|
May 15, 2025
Q1 2025
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-269K- 85.79% |
$1.01M - $1.72M
|
44.6K
$204K
|
|
|
May 15, 2025
Q1 2025
|
Bvf Inc
San Francisco, CA |
SELL
|
- |
-420K- 7.35% |
$1.58M - $2.68M
|
5.3M
$24.2M
|
|
|
May 15, 2025
Q1 2025
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-485K- 96.04% |
$1.83M - $3.1M
|
20K
$91.5K
|
|
|
May 15, 2025
Q1 2025
|
Paradigm Biocapital Advisors LP
New York, NY |
SELL
|
- |
-564K- 7.72% |
$2.12M - $3.6M
|
6.74M
$30.8M
|
|
|
May 15, 2025
Q1 2025
|
Morgan Stanley
New York, NY |
SELL
|
- |
-573K- 55.91% |
$2.15M - $3.66M
|
452K
$2.06M
|
|
|
May 15, 2025
Q1 2025
|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
SELL
|
- |
-626K- 8.38% |
$2.35M - $4M
|
6.84M
$31.3M
|
|
|
May 14, 2025
Q1 2025
|
Candriam S.C.A.
|
SELL
|
- |
-701K- 45.18% |
$2.64M - $4.48M
|
851K
$3.89M
|
|
|
May 15, 2025
Q1 2025
|
State Street Corp
Boston, MA |
SELL
|
- |
-992K- 53.4% |
$3.73M - $6.34M
|
866K
$3.96M
|
|
|
May 15, 2025
Q1 2025
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-1.01M- 89.98% |
$3.81M - $6.48M
|
113K
$516K
|
|
|
May 15, 2025
Q1 2025
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-2.23M- 60.73% |
$8.38M - $14.2M
|
1.44M
$6.59M
|